Details for New Drug Application (NDA): 205239
✉ Email this page to a colleague
The generic ingredient in DANTROLENE SODIUM is dantrolene sodium. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the dantrolene sodium profile page.
Summary for 205239
Tradename: | DANTROLENE SODIUM |
Applicant: | Eugia Pharma Speclts |
Ingredient: | dantrolene sodium |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 205239
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/VIAL | ||||
Approval Date: | Feb 18, 2016 | TE: | RLD: | No |
Complete Access Available with Subscription